What You Should Know:
- FeelBetter, the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced a collaboration on a prospective research study with investigators at Brigham and Women’s Hospital in Boston.
- The research will assess the impact of FeelBetter’s AI-based
Read More
Humana Expands Use of Cohere Health’s Prior Authorization Platform
What You Should Know:
- Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere's prior authorization platform for diagnostic imaging and sleep services.
- In January 2021, Cohere and Humana began a pilot
Read More
Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device. With affordable, AI-powered medical imaging in a pocket-sized device, caregivers can get to answers immediately to accelerate diagnosis and create new care pathways for heart failure patients at the point of care. As
Read More
Ultrahuman Opens U.S. Manufacturing Facility for Wearable Rings
What You Should Know:
- With smart ring market leadership within its sights, Ultrahuman has today announced plans to open a manufacturing facility poised to accelerate its production capacity.
- The UltraFactory will be located in Indiana. It opens within the next six months and will be the launchpad for Ultrahuman’s next phase of growth.
Ultrahuman Sets Industry Benchmark with Launch of
Read More
Medixine & Nonin Medical to Co-Develop Remote Patient Monitoring Services
What You Should Know:
- Finnish health tech company Medixine has strengthened its presence in the U.S. market, announcing a deepened technological partnership with Nonin Medical, a leading manufacturer of wearable and noninvasive medical monitoring devices.
- With the U.S. market for remote patient monitoring expected to
Read More
Lumeris Secures $100M to Expand Proven Value-Based Care Solutions
What You Should Know:
- St. Louis-based, privately held Lumeris announced the completion of a $100M equity capital raise.
- The funding round was led by Deerfield Management, a longstanding lender, and new investor Endeavor Health. Existing investors Kleiner Perkins, Sandbox Industries, BlueCross BlueShield Venture Partners and JDLinx
Read More
Nibble Health Officially Re-Launches As Standard Practice, Changing How Medical Practices Operate
What You Should Know:
- Standard Practice, a voice-AI platform that automates medical practices’ outbound calls to insurance and pharmacies, today announced its official re-launch into the healthcare market since pivoting from Nibble Health.
- Co-founded by reformed investment banker Steven Greene and technical product and engineering leader Phil Markunas, Standard Practice offers a transformative healthcare solution designed to streamline administrative tasks and enhance revenue
Read More
Epicore Biosystems Launches Connected Hydration
What You Should Know:
- Epicore Biosystems (‘Epicore’), a digital health company developing advanced sweat-sensing wearables to provide real-time personalized hydration insights for performance and safety, today announced the commercial launch of Connected Hydration.
- Connected Hydration is the first sweat-sensing wearable patch and
Read More
Ilant Health Secures $5.5M for Value-Based Obesity Management & Cardiometabolic Health
What You Should Know:
- Ilant Health, a pioneering leader in value-based obesity management and cardiometabolic health solutions, announced today the extension of its seed round of fundraising from $3 million to $5.5 million.
- The women-led startup received additional funds from a combination of new health-oriented investors, including
Read More
Isospec Analytics Secures $1.9M to Transform Molecular Identification
What You Should Know:
- When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger.
- Isospec Analytics
Read More
